Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
115.50 USD | +0.52% | -0.68% | +4.93% |
Capitalization | 200B 191B 177B 157B 284B 17,000B 314B 2,200B 812B 6,981B 752B 736B 30,463B | P/E ratio 2024 * |
33.7x | P/E ratio 2025 * | 29.1x |
---|---|---|---|---|---|
Enterprise value | 207B 197B 182B 162B 293B 17,548B 325B 2,271B 838B 7,205B 776B 760B 31,444B | EV / Sales 2024 * |
4.92x | EV / Sales 2025 * | 4.57x |
Free-Float |
-
| Yield 2024 * |
1.91% | Yield 2025 * | 2.02% |
Last Transcript: Abbott Laboratories
1 day | +0.52% | ||
1 week | -0.68% | ||
Current month | -2.75% | ||
1 month | -0.93% | ||
3 months | -1.37% | ||
6 months | +7.45% | ||
Current year | +4.93% |
Director | Title | Age | Since |
---|---|---|---|
Robert Ford
CEO | Chief Executive Officer | 50 | 2020-03-30 |
Philip Boudreau
DFI | Director of Finance/CFO | 51 | 2023-08-31 |
Scott House
CTO | Chief Tech/Sci/R&D Officer | - | 2020-02-29 |
Manager | Title | Age | Since |
---|---|---|---|
Robert Alpern
BRD | Director/Board Member | 73 | 2008-10-09 |
Sally Blount
BRD | Director/Board Member | 62 | 2011-12-08 |
Nancy McKinstry
BRD | Director/Board Member | 65 | 2011-12-08 |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
7.18% | 20 M€ | +16.14% | - | |
5.19% | 2 M€ | -.--% | ||
3.00% | 2 M€ | -.--% | - |
Change | 5d. change | 1-year change | 3-years change | Capi. ($) | ||
---|---|---|---|---|---|---|
+0.52% | -0.68% | +10.52% | -14.04% | 200B | ||
-0.45% | -2.49% | +5.33% | -25.66% | 107B | ||
-0.70% | +0.08% | -4.67% | -9.61% | 64.02B | ||
-0.34% | +2.16% | +20.07% | +14.13% | 46.64B | ||
-1.46% | -5.21% | +17.48% | +92.49% | 45.81B | ||
+1.28% | -1.85% | -32.11% | -43.93% | 31.02B | ||
+0.46% | -1.90% | +27.84% | +28.57% | 29.46B | ||
-0.90% | -0.81% | -6.71% | -26.02% | 23.12B | ||
-0.98% | -2.11% | -7.59% | -12.92% | 21.58B | ||
-0.65% | -1.12% | +6.84% | -6.78% | 21.15B | ||
Average | -0.32% | -1.56% | +3.70% | -0.38% | 59.03B | |
Weighted average by Cap. | -0.13% | -1.69% | +6.38% | -4.79% |
2024 * | 2025 * | |
---|---|---|
Net sales | 42B 39.97B 37.04B 32.95B 59.48B 3,564B 65.92B 461B 170B 1,463B 158B 154B 6,386B | 44.98B 42.81B 39.67B 35.28B 63.7B 3,817B 70.59B 494B 182B 1,567B 169B 165B 6,839B |
Net income | 5.94B 5.65B 5.24B 4.66B 8.41B 504B 9.32B 65.22B 24.07B 207B 22.29B 21.81B 903B | 6.85B 6.52B 6.04B 5.38B 9.7B 581B 10.75B 75.25B 27.78B 239B 25.72B 25.17B 1,042B |
Net Debt | 6.45B 6.14B 5.69B 5.06B 9.14B 547B 10.13B 70.85B 26.16B 225B 24.22B 23.7B 981B | 5.08B 4.84B 4.49B 3.99B 7.2B 432B 7.98B 55.85B 20.62B 177B 19.09B 18.68B 773B |
Date | Price | Change | Volume |
---|---|---|---|
24-12-10 | 115.50 $ | +0.52% | 4,072,098 |
24-12-09 | 114.90 $ | -0.61% | 4,868,047 |
24-12-06 | 115.60 $ | +0.01% | 5,300,680 |
24-12-05 | 115.59 $ | -0.33% | 3,269,799 |
24-12-04 | 115.97 $ | -0.28% | 3,557,185 |
Delayed Quote Nyse, December 10, 2024 at 04:00 pm EST
More quotesQuarterly revenue - Rate of surprise
- Stock Market
- Equities
- ABT Stock